Perrigo Company plc (NYSE:PRGO) is a global consumer self-care company that specializes in providing over-the-counter health and wellness solutions. The company operates in the pharmaceutical industry, competing with other major players like Johnson & Johnson and Procter & Gamble. On August 8, 2025, Lockwood-Taylor Patrick, the director and CEO of Perrigo, made a notable move by purchasing 4,060 shares of the company's Ordinary Shares at $22.37 each. This transaction increased his total holdings to 85,412 shares.
Despite the recent purchase by the CEO, Perrigo's stock has faced challenges, with a 16.3% decline over the past four weeks. This drop has placed the stock in what is considered oversold territory, as indicated by the Relative Strength Index (RSI). An RSI reading below 30 suggests that the stock may be undervalued, potentially signaling a buying opportunity for investors.
The current stock price of PRGO stands at $22.78, reflecting a slight decrease of 0.22% with a change of $0.05. The stock has experienced fluctuations today, ranging from a low of $22.33 to a high of $22.95. Over the past year, PRGO has seen a high of $30.93 and a low of $21.03, indicating some volatility in its performance.
Perrigo's market capitalization is approximately $3.13 billion, and the stock is actively traded with a volume of 759,314 shares. Analysts on Wall Street are optimistic about the company's future, with expectations of upward revisions in earnings estimates. This positive sentiment suggests that a trend reversal may be on the horizon for PRGO, potentially benefiting investors who are considering entering the market at this time.
